您的当前位置:首页 > 行业数据 > 替尔泊肽高剂量组恶心、腹泻比例超过20%
图片属性
图片格式:PNG 图片大小:145KB 图片尺寸:1169*941
同报告图片
 / 4
替尔泊肽高剂量组恶心、腹泻比例超过20%_第1页
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
替尔泊肽高剂量组恶心、腹泻比例超过20%_第2页
替尔泊肽高剂量组恶心、腹泻比例超过20%_第3页
替尔泊肽高剂量组恶心、腹泻比例超过20%_第4页
替尔泊肽高剂量组恶心、腹泻比例超过20%_第5页
所属报告: 【国金证券】医药行业研究:GLP-1专题,产品迭代驱动市场扩容,关注靶点、剂型及联合疗法研发进展-251117(38页).pdf
打包全文图表

相关数据

客服
商务合作
小程序
服务号
折叠